Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Translated into:
Welcome To Welox Pharma WHO-GMP | ISO 9001:2015
Rhoclone 300mcg Injection: Safeguarding Against Infections
Introduction:
Rhoclone 300mcg Injection takes the stage as a preventive measure against infections, specifically tailored to thwart the formation of antibodies. It proves instrumental when an individual with Rh-negative blood is exposed to Rh-positive blood, be it through bonding or pregnancy-related complications.
Uses of Rhoclone 300mcg Injection:
This injection is primarily employed for Rh prophylaxis in pregnancy-related complexities. It finds further application in scenarios where Rh-negative individuals are bonded with blood components containing Rh-positive red blood cells (RBCs). Rhoclone 300mcg Injection may also be prescribed for immune thrombocytopenic purpura, a condition characterized by a decrease in circulating platelets, leading to easy bruising.
Benefits of Rhoclone 300mcg Injection:
In the realm of infection prevention, Rhoclone 300mcg Injection plays a pivotal role. As an immunoglobulin, it actively hinders the formation of antibodies in scenarios involving Rh-negative individuals coming into contact with Rh-positive blood, especially during pregnancy. Administered typically during the third trimester for RhD-negative pregnant individuals, it aims to counteract the potential transfer of fetal RhD-positive blood into the maternal circulation.
Mechanism of Action of Rhoclone 300mcg Injection:
Belonging to the class of drugs known as immunoglobulins, Rhoclone 300mcg Injection exerts its influence by eliminating or neutralizing fetal Rhesus-D positive red blood cells that may enter the maternal bloodstream during childbirth, abortion, or any intervention during pregnancy that could result in bleeding across the placenta.